These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 326683)

  • 1. Tumor regression after intralesional injection of emulsified trehalose-6,6'-dimycolate (cord factor): efficacy increases with oil concentration.
    Yarkoni E; Meltzer MS; Rapp HJ
    Int J Cancer; 1977 Jun; 19(6):818-21. PubMed ID: 326683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy with an intralesionally administered synthetic cord factor analogue.
    Yarkoni E; Rapp HJ; Polonsky J; Lederer E
    Int J Cancer; 1978 Nov; 22(5):564-9. PubMed ID: 721317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor regression after intralesional injection of mycobacterial components emulsified in 2,6,10,15,19,23-hexamethyl-2,6,10,14,18,22-tetracosahexaene (squalene), 2,6,10,15,19,23-hexamethyltetracosane (squalane), peanut oil, or mineral oil.
    Yarkoni E; Rapp HJ
    Cancer Res; 1979 May; 39(5):1518-20. PubMed ID: 427795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy of an ascitic rat hepatoma with cord factor (trehalose-6, 6'-dimycolate) and synthetic analogues.
    Pimm MV; Baldwin RW; Polonsky J; Lederer E
    Int J Cancer; 1979 Dec; 24(6):780-5. PubMed ID: 544531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression of a murine fibrosarcoma after intralesional injection of a synthetic C39 glycolipid related to cord factor.
    Yarkoni E; Rapp HJ; Polonsky J; Varenne J; Lederer E
    Infect Immun; 1979 Nov; 26(2):462-6. PubMed ID: 546783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of oil and Tween concentrations on enhanced endotoxin lethality in mice pretreated with emulsified trehalose-6,6'-dimycolate (cord factor).
    Yarkoni E; Rapp HJ
    Infect Immun; 1979 May; 24(2):571-2. PubMed ID: 378860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathology of tumor regression by cord factor, turpentine or endotoxin, dissociation of therapy and granuloma formation.
    Yarkoni E; Ruco LP; Rapp HJ; Meltzer MS
    Eur J Cancer (1965); 1979 Nov; 15(11):1401-7. PubMed ID: 527631
    [No Abstract]   [Full Text] [Related]  

  • 8. Toxicity of emulsified trehalose-6,6'-dimycolate (cord factor) in mice depends on size distribution of mineral oil droplets.
    Yarkoni E; Rapp HJ
    Infect Immun; 1978 Jun; 20(3):856-60. PubMed ID: 669824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regression of tumors in guinea pigs after treatment with synthetic muramyl dipeptides and trehalose dimycolate.
    McLaughlin CA; Schwartzman SM; Horner BL; Jones GH; Moffatt JG; Nestor JJ; Tegg D
    Science; 1980 Apr; 208(4442):415-6. PubMed ID: 7189295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of sulfolipid I on trehalose-6,6'-dimycolate (cord factor) toxicity and antitumor activity.
    Yarkoni E; Goren MB; Rapp HJ
    Infect Immun; 1979 May; 24(2):586-8. PubMed ID: 457287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granuloma formation in lungs of mice after intravenous administration of emulsified trehalose-6,6'-dimycolate (cord factor): reaction intensity depends on size distribution of the oil droplets.
    Yarkoni E; Rapp HJ
    Infect Immun; 1977 Nov; 18(2):552-4. PubMed ID: 924683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy and vaccination against cancer with non-living BCG and cord factor (trehalose-6,6'-dimycolate).
    Bekierkunst A
    Int J Cancer; 1975 Sep; 16(3):442-7. PubMed ID: 170221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of mycosis fungoides with heat-killed BCG and cord factor.
    Cohen HA; Bekierkunst A
    Dermatologica; 1979; 158(2):104-16. PubMed ID: 761694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of interferon in the augmented resistance of trehalose-6,6'-dimycolate-treated mice to influenza virus infection.
    Azuma M; Suzutani T; Sazaki K; Yoshida I; Sakuma T; Yoshida T
    J Gen Virol; 1987 Mar; 68 ( Pt 3)():835-43. PubMed ID: 3493326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of urethan-induced lung adenomas in mice treated with trehalose-6,6-dimycolate (cord factor) and living bacillus Calmette Guérin.
    Bekierkunst A; Levij IS; Yarkoni E
    Science; 1971 Dec; 174(4015):1240-2. PubMed ID: 5002466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo activity of released cell wall lipids of Mycobacterium bovis bacillus Calmette-Guérin is due principally to trehalose mycolates.
    Geisel RE; Sakamoto K; Russell DG; Rhoades ER
    J Immunol; 2005 Apr; 174(8):5007-15. PubMed ID: 15814731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of surfactant concentration on the antitumor activity of emulsified components of mycobacteria.
    Yarkoni E; Rapp HJ
    Cancer Res; 1980 Apr; 40(4):975-8. PubMed ID: 7357563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of pulmonary granulomas, macrophage procoagulant activity, and tumor necrosis factor-alpha by trehalose glycolipids.
    Behling CA; Perez RL; Kidd MR; Staton GW; Hunter RL
    Ann Clin Lab Sci; 1993; 23(4):256-66. PubMed ID: 8373130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy with nonviable microbial components.
    Ribi E; Milner KC; Granger DL; Kelly MT; Yamamoto K; Brehmer W; Parker R; Smith RF; Strain SM
    Ann N Y Acad Sci; 1976; 277(00):228-38. PubMed ID: 187099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of delayed-type sensitivity to Leishmania parasite in a case of leishmaniasis cutanea diffusa with BCG and cord-factor (Trehalose-6-6' dimycolate).
    Cohen HA
    Acta Derm Venereol; 1979; 59(6):547-9. PubMed ID: 94221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.